NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 315 filers reported holding NEOGENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,386,547 | -23.4% | 1,576,142 | +0.1% | 0.00% | -20.0% |
Q2 2023 | $25,315,296 | -6.1% | 1,575,314 | +1.7% | 0.01% | 0.0% |
Q1 2023 | $26,971,694 | +87.5% | 1,549,207 | -0.5% | 0.01% | +66.7% |
Q4 2022 | $14,382,207 | +1.8% | 1,556,516 | -5.2% | 0.00% | 0.0% |
Q3 2022 | $14,130,000 | +37.8% | 1,641,073 | +30.4% | 0.00% | +50.0% |
Q2 2022 | $10,256,000 | -43.9% | 1,258,587 | -16.4% | 0.00% | -33.3% |
Q1 2022 | $18,287,000 | -65.5% | 1,505,064 | -3.1% | 0.00% | -66.7% |
Q4 2021 | $52,979,000 | -29.9% | 1,552,736 | -0.9% | 0.01% | -30.8% |
Q3 2021 | $75,592,000 | +5.8% | 1,567,001 | -1.0% | 0.01% | 0.0% |
Q2 2021 | $71,479,000 | -5.6% | 1,582,464 | +0.8% | 0.01% | -7.1% |
Q1 2021 | $75,692,000 | -9.2% | 1,569,396 | +1.3% | 0.01% | -12.5% |
Q4 2020 | $83,401,000 | +45.9% | 1,549,050 | -0.1% | 0.02% | +23.1% |
Q3 2020 | $57,174,000 | +14.1% | 1,549,839 | -4.2% | 0.01% | +8.3% |
Q2 2020 | $50,115,000 | +23.4% | 1,617,664 | +9.9% | 0.01% | 0.0% |
Q1 2020 | $40,622,000 | -12.6% | 1,471,276 | -7.4% | 0.01% | +20.0% |
Q4 2019 | $46,484,000 | +49.1% | 1,589,220 | -2.5% | 0.01% | +42.9% |
Q3 2019 | $31,176,000 | -1.5% | 1,630,559 | +13.0% | 0.01% | -12.5% |
Q2 2019 | $31,654,000 | +12.2% | 1,442,753 | +4.6% | 0.01% | +14.3% |
Q1 2019 | $28,216,000 | +97.3% | 1,379,093 | +21.6% | 0.01% | +75.0% |
Q4 2018 | $14,300,000 | -18.6% | 1,133,992 | -1.0% | 0.00% | 0.0% |
Q3 2018 | $17,575,000 | +34.2% | 1,144,946 | +14.6% | 0.00% | +33.3% |
Q2 2018 | $13,094,000 | +64.1% | 998,807 | +2.2% | 0.00% | +50.0% |
Q1 2018 | $7,977,000 | -6.7% | 977,514 | +1.3% | 0.00% | 0.0% |
Q4 2017 | $8,547,000 | -21.7% | 964,594 | -1.6% | 0.00% | -33.3% |
Q3 2017 | $10,913,000 | +24.3% | 980,484 | +0.1% | 0.00% | +50.0% |
Q2 2017 | $8,780,000 | +25.7% | 979,841 | +10.6% | 0.00% | 0.0% |
Q1 2017 | $6,987,000 | -6.6% | 885,564 | +1.4% | 0.00% | 0.0% |
Q4 2016 | $7,482,000 | +1.5% | 872,975 | -2.7% | 0.00% | 0.0% |
Q3 2016 | $7,373,000 | +4.1% | 896,899 | +1.8% | 0.00% | 0.0% |
Q2 2016 | $7,084,000 | +37.0% | 881,140 | +12.3% | 0.00% | 0.0% |
Q1 2016 | $5,169,000 | -14.5% | 784,755 | +2.2% | 0.00% | 0.0% |
Q4 2015 | $6,043,000 | +59.2% | 767,834 | +15.9% | 0.00% | +100.0% |
Q3 2015 | $3,796,000 | +600.4% | 662,568 | +560.7% | 0.00% | – |
Q2 2015 | $542,000 | +8.0% | 100,283 | -6.7% | 0.00% | – |
Q1 2015 | $502,000 | +12.1% | 107,518 | 0.0% | 0.00% | – |
Q4 2014 | $448,000 | -25.3% | 107,518 | -6.7% | 0.00% | – |
Q3 2014 | $600,000 | -50.1% | 115,203 | -68.2% | 0.00% | – |
Q2 2014 | $1,202,000 | -24.9% | 362,120 | -21.5% | 0.00% | -100.0% |
Q1 2014 | $1,600,000 | -2.4% | 461,461 | +1.8% | 0.00% | 0.0% |
Q4 2013 | $1,640,000 | +23.3% | 453,232 | +2.2% | 0.00% | – |
Q3 2013 | $1,330,000 | +87.3% | 443,691 | +148.8% | 0.00% | – |
Q2 2013 | $710,000 | – | 178,347 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |